hard · Private Equity & LBOs
A GP sells a portfolio company to a continuation fund it also manages, crystallizing carry on the legacy fund while LPs are offered the choice to roll or cash out.
From a fundamental alignment standpoint, what is the most acute conflict of interest that fairness mechanisms (independent valuation, LPAC consent, status-quo default) are specifically designed to address?
- The GP both prices and stands on both sides of the transaction, so it is incentivized to set a transfer price that suits its own carry crystallization rather than maximize value for selling LPs
- The GP earns management fees on the new continuation vehicle, which mechanically reduces the net return delivered to rolling LPs below the headline gross figure
- The continuation fund extends the asset's hold period beyond the original fund term, breaching the fund's stated investment horizon and triggering an unwind
- Rolling LPs face a tax timing mismatch because the sale is a deemed disposition even when no cash changes hands for them
Sign up free to see the explanation and track your rank →
More Private Equity & LBOs practice
- If the GP receives a 20% carry on the profit from Deal A immediately, and the fund eventua
- Following the investment, what is the investor's ownership percentage in the company, assu
- What is the Interest Coverage Ratio?
- A private equity firm is calculating a 'Public Market Equiva… — If the KS-PME score is 1.1
- A sponsor provides an 'Equity Cure' to a portfolio company. What is the standard purpose o
- What is the new effective conversion price for the growth equity investor?
- Which company will report a higher 'Gross Margin' and a higher ending 'Inventory' value on
- What is the company's Interest Coverage Ratio?